Stockscreener 앱 받기
9.73
5.07%
-0.52
시간 외 거래:
9.71
-0.02
-0.21%
전일 마감가:
$10.25
열려 있는:
$10.24
하루 거래량:
2.31M
Relative Volume:
0.38
시가총액:
$759.48M
수익:
-
순이익/손실:
$-209.96M
주가수익비율:
-3.0791
EPS:
-3.16
순현금흐름:
$-176.27M
1주 성능:
+10.57%
1개월 성능:
+132.22%
6개월 성능:
-0.51%
1년 성능:
-17.26%
1일 변동 폭
$9.70
$10.35
1주일 범위
$9.095
$10.85
52주 변동 폭
$2.68
$17.00
레플리뮨 Stock (REPL) Company Profile
명칭
Replimune Group Inc
전화
(781) 222-9600
주소
500 UNICORN PARK, WOBURN, MA
REPL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
9.73 | 800.07M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
레플리뮨 Stock (REPL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-20 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2025-10-20 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-10-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-10-20 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2025-09-19 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-07-30 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-07-23 | 다운그레이드 | BMO Capital Markets | Outperform → Underperform |
| 2025-07-23 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-07-23 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-07-22 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-22 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-07-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-22 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2025-06-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2023-04-17 | 재개 | Piper Sandler | Overweight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2020-11-17 | 개시 | BTIG Research | Buy |
| 2020-11-02 | 개시 | Jefferies | Buy |
| 2020-10-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2019-09-04 | 개시 | ROTH Capital | Buy |
| 2019-07-23 | 개시 | Chardan Capital Markets | Buy |
| 2019-07-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-07-08 | 개시 | H.C. Wainwright | Buy |
| 2019-04-25 | 개시 | Wedbush | Outperform |
| 2019-01-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-08-14 | 개시 | JP Morgan | Overweight |
| 2018-08-14 | 개시 | Leerink Partners | Outperform |
모두보기
레플리뮨 주식(REPL)의 최신 뉴스
How Replimune Group Inc. stock compares to growth peers2025 Performance Recap & Fast Entry High Yield Tips - newser.com
Trend analysis for Replimune Group Inc. this weekTrade Ideas & Daily Stock Momentum Reports - newser.com
What recovery options are there for Replimune Group Inc.Volume Spike & Real-Time Price Movement Reports - newser.com
How to build a custom watchlist for Replimune Group Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
Price momentum metrics for Replimune Group Inc. explainedMarket Rally & Consistent Growth Equity Picks - newser.com
Will Replimune Group Inc. stock benefit from AI adoptionWatch List & Trade Opportunity Analysis Reports - newser.com
What to do if you’re stuck in Replimune Group Inc.Market Sentiment Summary & Daily Price Action Insights - newser.com
Why Replimune Group Inc. stock is a must watch in 2025Trade Signal Summary & Daily Profit Maximizing Tips - newser.com
What hedge fund activity signals for Replimune Group Inc. stock2025 Market Sentiment & Weekly Stock Breakout Alerts - newser.com
How to use Fibonacci retracement on Replimune Group Inc.Trade Volume Summary & High Win Rate Trade Alerts - newser.com
What risks investors should watch in Replimune Group Inc. stockJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
Brokers Set Expectations for Replimune Group Q2 Earnings - MarketBeat
Is Replimune Group Inc. stock a buy before product launchesEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
Replimune Group (NASDAQ:REPL) Stock Price Up 9.2% After Analyst Upgrade - MarketBeat
HC Wainwright Forecasts Replimune Group Q2 Earnings - MarketBeat
Replimune Group (REPL) Price Target Increased by 48.75% to 10.84 - Nasdaq
Traders Buy High Volume of Call Options on Replimune Group (NASDAQ:REPL) - MarketBeat
How Replimune Group Inc. stock reacts to Fed rate cuts2025 Year in Review & Fast Gaining Stock Reports - Fundação Cultural do Pará
Replimune Group, Inc. (NASDAQ:REPL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Published on: 2025-10-27 17:22:37 - newser.com
Opinion | The Spin Doctors at the FDA - The Wall Street Journal
HC Wainwright Upgrades Replimune Group to Buy From Neutral, Price Target is $12 - MarketScreener
H.C. Wainwright upgrades Replimune stock rating to Buy on RP1 approval chances - Investing.com Canada
Replimune Group (NASDAQ:REPL) Upgraded to Buy at HC Wainwright - MarketBeat
HC Wainwright & Co. Upgrades Replimune Group (REPL) - Nasdaq
REPL Receives Analyst Upgrade and New Price Target Today | REPL Stock News - GuruFocus
레플리뮨 (REPL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):